Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 1998, p. 2810-2816, Vol. 36, No. 10
Department of Medicine,
Received 31 March 1998/Returned for modification 8 June
1998/Accepted 30 June 1998
Molecular methods are increasingly used to identify microbes in
clinical samples. A common technical problem with PCR is failed amplification due to the presence of PCR inhibitors. Initial attempts at amplification of the bacterial 16S rRNA gene from inoculated blood
culture media failed for this reason. The inhibitor persisted, despite
numerous attempts to purify the DNA, and was identified as sodium
polyanetholesulfonate (SPS), a common additive to blood culture media.
Like DNA, SPS is a high-molecular-weight polyanion that is soluble in
water but insoluble in alcohol. Accordingly, SPS tends to copurify with
DNA. An extraction method was designed for purification of DNA from
blood culture media and removal of SPS. Blood culture media containing
human blood and spiked with Escherichia coli was subjected
to an organic extraction procedure with benzyl alcohol, and removal of
SPS was documented spectrophotometrically. Successful amplification of
the extracted E. coli 16S rRNA gene was achieved by adding
5 µl of undiluted processed sample DNA to a 50-µl PCR mixture. When
using other purification methods, the inhibitory effect of SPS could be
overcome only by dilution of these samples. By our extraction
technique, even uninoculated blood culture media were found to contain
bacterial DNA when they were subjected to broad-range 16S rRNA gene
consensus PCR. We conclude that the blood culture additive SPS is a
potent inhibitor of PCR, is resistant to removal by traditional DNA
purification methods, but can be removed by a benzyl alcohol extraction
protocol that results in improved PCR performance.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Improved Amplification of Microbial DNA from Blood Cultures
by Removal of the PCR Inhibitor Sodium
Polyanetholesulfonate
*
Corresponding author. Mailing address: Veterans Affairs
Palo Alto Health Care System 154-T, 3801 Miranda Ave., Palo Alto, CA
94304. Phone: (650) 493-5000, ext. 63163. Fax: (650) 852-3291. E-mail:
fredrick{at}cmgm.stanford.edu.
Journal of Clinical Microbiology, October 1998, p. 2810-2816, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|